JPRN-UMIN000053025招募中未知
Efficacy and Safety of biosimilar to Crohn's disease and ulcerative colitis: prospective cohort observational study - IBD biosimilar study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients without definite diagnosis of Crohn's disease or ulcerative colitis. 2. Patients who have previously received either Infliximab BS or Adalimumab BS. 3. Patients who are judged by the researchers to be unsuitable as research subjects.
研究者
相似试验
已完成
不适用
Biologica in patients with Crohn's disease in GermanyK50Crohn disease [regional enteritis]DRKS00009234CED Service GmbH1,550
已完成
不适用
Therapeutic Effect of New Biologics in Crohn's DiseaseInflammatory Bowel DiseasesTreatment Side EffectsUlcerative ColitisCrohn DiseaseNCT04923100Sixth Affiliated Hospital, Sun Yat-sen University50
进行中（未招募）
1 期
Biological therapy in the prevention of Crohn`s disease recurrence after resection in ileocecal region.Prevention of Crohn`s disease recurrence after surgery in ileocecal region by postoperative application of infliximab (four infusions).MedDRA version: 9.1 Level: LLT Classification code 10011401 Term: Crohn's diseaseEUCTR2008-005688-32-CZniveristy Hospital Na Bulovce50
已完成
不适用
A Double Blind , Randomised, Placebo Controlled Trial to Determine the Efficacy of the probiotic VSL#3 in Preventing Relapse in Children with Crohn’s Disease – 12-month long term studyCrohn's diseaseOral and Gastrointestinal - Crohn's diseaseACTRN12611001267943Sydney Chidlren's hospital36
进行中（未招募）
1 期
Bloodflow measurements in stenotic inflammatory bowel disease.EUCTR2011-005846-36-DKGastroenterology MIDT25